Harbourvest Partners’s CytomX Therapeutics CTMX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-79,193
| Closed | -$343K | – | 68 |
|
|
2021
Q4 | $343K | Hold |
79,193
| – | – | 0.04% | 54 |
|
|
2021
Q3 | $403K | Hold |
79,193
| – | – | 0.04% | 46 |
|
|
2021
Q2 | $501K | Hold |
79,193
| – | – | 0.05% | 38 |
|
|
2021
Q1 | $612K | Hold |
79,193
| – | – | 0.08% | 29 |
|
|
2020
Q4 | $519K | Hold |
79,193
| – | – | 0.2% | 17 |
|
|
2020
Q3 | $527K | Hold |
79,193
| – | – | 0.2% | 24 |
|
|
2020
Q2 | $660K | Hold |
79,193
| – | – | 0.28% | 19 |
|
|
2020
Q1 | $607K | Hold |
79,193
| – | – | 0.29% | 25 |
|
|
2019
Q4 | $658K | Hold |
79,193
| – | – | 0.27% | 25 |
|
|
2019
Q3 | $584K | Hold |
79,193
| – | – | 0.24% | 21 |
|
|
2019
Q2 | $889K | Hold |
79,193
| – | – | 0.33% | 21 |
|
|
2019
Q1 | $851K | Hold |
79,193
| – | – | 0.3% | 21 |
|
|
2018
Q4 | $1.2M | Hold |
79,193
| – | – | 0.57% | 18 |
|
|
2018
Q3 | $1.43M | Hold |
79,193
| – | – | 1.29% | 12 |
|
|
2018
Q2 | $1.81M | Buy |
+79,193
| New | +$1.81M | 2.29% | 10 |
|
|
2017
Q3 | – | Sell |
-39,199
| Closed | -$608K | – | 23 |
|
|
2017
Q2 | $608K | Buy |
39,199
+14,199
| +57% | +$220K | 0.26% | 14 |
|
|
2017
Q1 | $432K | Buy |
25,000
+15,000
| +150% | +$259K | 0.24% | 14 |
|
|
2016
Q4 | $110K | Buy |
+10,000
| New | +$110K | 0.07% | 16 |
|
|
2016
Q3 | – | Sell |
-10,000
| Closed | -$102K | – | 12 |
|
|
2016
Q2 | $102K | Buy |
+10,000
| New | +$102K | 0.05% | 20 |
|